Showing results (1561-1570 of 1,734) with videos related to
Sort By:
Pageof 174
Human Molecular Genetics|November 18, 2008
Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosisSergio E Baranzini, Joanne Wang, Rachel A Gibson, et al.Human Molecular Genetics|November 13, 2013
DNAJC13 mutations in Parkinson diseaseCarles Vilariño-Güell, Alex Rajput, Austen J Milnerwood, et al.The Lancet. Neurology|October 5, 2007
Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control studyGianpiero L Cavalleri, Michael E Weale, Kevin V Shianna, et al.Brain : a Journal of Neurology|June 5, 2010
Common genetic variation and susceptibility to partial epilepsies: a genome-wide association studyDalia Kasperaviciūte, Claudia B Catarino, Erin L Heinzen, et al.Science (New York, N.Y.)|November 2, 2021
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19Dafydd R Owen, Charlotte M N Allerton, Annaliesa S Anderson, et al.Archives of Neurology|November 14, 2007
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer diseaseHao Li, Sally Wetten, Li Li, et al.American Journal of Human Genetics|April 20, 2010
Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromesErin L Heinzen, Rodney A Radtke, Thomas J Urban, et al.American Journal of Human Genetics|September 13, 2011
Translation initiator EIF4G1 mutations in familial Parkinson diseaseMarie-Christine Chartier-Harlin, Justus C Dachsel, Carles Vilariño-Güell, et al.Journal of Medicinal Chemistry|April 30, 2024
A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19Charlotte M N Allerton, Joel T Arcari, Lisa M Aschenbrenner, et al.Journal of Medicinal Chemistry|February 28, 2025
Discovery of Nirmatrelvir (PF-07321332): A Potent, Orally Active Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Main ProteaseJamison B Tuttle, Christophe Allais, Charlotte M N Allerton, et al.Pageof 174